Hanmi Pharmaceutical Launches Innovative Vial Dispensing System
Hanmi Pharmaceutical Expands into North American Markets
Hanmi Pharmaceutical Global Business Headquarters is making significant strides in expanding its presence in the North American markets. Through collaboration with its distribution partner, McKesson, Hanmi aims to offer innovative solutions tailored for Canadian and American pharmacists.
Introducing Countmate for Vial Dispensing
Recently, Hanmi has launched a groundbreaking product known as Countmate, a fully automated vial dispensing machine. This solution is specifically designed to cater to the unique needs of pharmacies across Canada and the US. The traditional practice in North America involves using vials for medication dispensing, contrasting with the pouch format commonly favored in other regions.
Streamlined Dispensing Process
The Countmate system aims to enhance the efficiency of pharmacy operations by automating several key processes. From counting medications to labeling and verifying images, this advanced technology simplifies the workflow for pharmacists, ensuring that they can manage their operations more effectively and with greater accuracy.
Collaboration with McKesson Automation
Understanding the intricacies of the North American pharmaceutical market, Hanmi Pharmaceutical has partnered with McKesson Automation, a leader in pharmacy automation. Their collaboration allows Countmate to be launched in a strategic manner, ensuring the system meets market needs. The official reveal of Countmate occurred during a prominent conference in New Orleans dedicated to pharmacy professionals.
ASHP Midyear Conference
The ASHP Midyear Conference serves as a vital platform for industry experts to converge and discuss developments within the field. It provides a venue for companies to exhibit their innovations, making it the perfect backdrop for the introduction of Countmate.
Technological Advancements in Countmate
Equipped with advanced technology, Countmate incorporates features aimed at revolutionizing pharmacy operations. From automatic drug counting to effective labeling via an orthogonal robot, the system undergoes rigorous image verification before finally discharging vials. This level of sophistication not only streamlines pharmacy operations but also enhances patient safety by reducing potential dispensing errors.
Configuration and Efficiency
Countmate can be customized with either 84 or 168 canisters, depending on the size and requirements of the pharmacy. This flexibility allows it to efficiently handle up to 160 prescriptions in an hour, making it an invaluable asset for busy pharmacies. Furthermore, integrated quality control measures ensure that every vial is thoroughly verified, maintaining a high standard of service.
Focused on Safety and User Convenience
In addition to its advanced operational features, Countmate prioritizes the safety and convenience of users. Safety sensors are built into the machine to prevent accidents, while the hygienic preparation processes guarantee contamination-free handling of vials. The compact design allows it to fit seamlessly into various pharmacy layouts, making it an adaptable choice for different working environments.
Future Prospects for Countmate
Hanmi anticipates that Countmate will be a game-changer in the realm of pharmacy automation, particularly for those pharmacies looking to integrate automated equipment into their workflow. The competitive pricing and comprehensive features make it an attractive choice for the market.
Continuing Strong Partnerships
The progression of Countmate's development involved close collaboration between Hanmi and JVM. Together, they focused on aligning the product’s functionalities with the specific needs and patterns prevalent in North American pharmaceutical practices. The partnership with McKesson remains pivotal to the success of Countmate, ensuring sustained growth and market penetration.
Commitment to Expansion
As Hanmi Pharmaceutical looks ahead, CEO Park Jae-hyun has stated the importance of pursuing new business opportunities that amplify synergy across their operations. This commitment to expanding their global reach emphasizes the company’s aspiration to enhance their international sales significantly.
Frequently Asked Questions
What is Countmate?
Countmate is an automated vial dispensing machine designed to streamline pharmacy operations and improve efficiency in medication handling.
How does Countmate enhance safety in pharmacies?
Countmate includes safety sensors to prevent accidents, ensuring a secure working environment for pharmacy staff.
Which markets is Hanmi targeting with Countmate?
Hanmi is targeting the Canadian and American markets, focusing on pharmacies that typically use vials for medication dispensing.
What are the key features of Countmate?
Countmate features automatic drug counting, precise vial labeling, image verification, and configurable canister options for different pharmacy sizes.
How does Hanmi plan to grow its market presence?
Hanmi aims to leverage strong partnerships, like its collaboration with McKesson, to expand its global footprint and increase sales in North America.
About The Author
Contact Kelly Martin privately here. Or send an email with ATTN: Kelly Martin as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.